J Anand, T Ghildiyal, A Madhwal, R Bhatt, D Verma… - 2021 - cabidigitallibrary.org
Background: In the current SARS-CoV-2 outbreak, drug repositioning emerges as a promising approach to develop efficient therapeutics in comparison to de novo drug …
J Anand, T Ghildiyal, A Madhwal, R Bhatt, D Verma… - Future …, 2021 - europepmc.org
Background: In the current SARS-CoV-2 outbreak, drug repositioning emerges as a promising approach to develop efficient therapeutics in comparison to de novo drug …
J Anand, T Ghildiyal, A Madhwal, R Bhatt… - Future …, 2021 - ncbi.nlm.nih.gov
Background: In the current SARS-CoV-2 outbreak, drug repositioning emerges as a promising approach to develop efficient therapeutics in comparison to de novo drug …
J Anand, T Ghildiyal, A Madhwal, R Bhatt, D Verma… - 2021 - scienceopen.com
Background: In the current SARS-CoV-2 outbreak, drug repositioning emerges as a promising approach to develop efficient therapeutics in comparison to de novo drug …
J Anand, T Ghildiyal, A Madhwal, R Bhatt… - Future …, 2021 - search.proquest.com
Background: In the current SARS-CoV-2 outbreak, drug repositioning emerges as a promising approach to develop efficient therapeutics in comparison to de novo drug …
J Anand, T Ghildiyal, A Madhwal, R Bhatt, D Verma… - 2021 - academia.edu
Background: In the current SARS-CoV-2 outbreak, drug repositioning emerges as a promising approach to develop efficient therapeutics in comparison to de novo drug …